首页> 外文会议>Conference on imaging-guided procedures, robotic interventions, and modeling >Deformable registration of X-ray to MRI for post-implant dosimetry in prostate brachytherapy
【24h】

Deformable registration of X-ray to MRI for post-implant dosimetry in prostate brachytherapy

机译:前列腺近距离放射治疗中X射线可变形对准MRI进行植入后剂量测定

获取原文

摘要

Post-implant dosimetric assessment in prostate brachytherapy is typically performed using CT as the standard imaging modality. However, poor soft tissue contrast in CT causes significant variability in target contouring, resulting in incorrect dose calculations for organs of interest. CT-MR fusion-based approach has been advocated taking advantage of the complementary capabilities of CT (seed identification) and MRI (soft tissue visibility), and has proved to provide more accurate dosimetry calculations. However, seed segmentation in CT requires manual review, and the accuracy is limited by the reconstructed voxel resolution. In addition, CT deposits considerable amount of radiation to the patient. In this paper, we propose an X-ray and MRI based post-implant dosimetry approach. Implanted seeds are localized using three X-ray images by solving a combinatorial optimization problem, and the identified seeds are registered to MR images by an intensity-based points-to-volume registration. We pre-process the MR images using geometric and Gaussian filtering. To accommodate potential soft tissue deformation, our registration is performed in two steps, an initial affine transformation and local deformable registration. An evolutionary optimizer in conjunction with a points-to-volume similarity metric is used for the affine registration. Local prostate deformation and seed migration are then adjusted by the deformable registration step with external and internal force constraints. We tested our algorithm on six patient data sets, achieving registration error of (1.2±0.8) mm in < 30 sec. Our proposed approach has the potential to be a fast and cost-effective solution for post-implant dosimetry with equivalent accuracy as the CT-MR fusion-based approach.
机译:通常使用CT作为标准成像模态进行前列腺近距离放射治疗的植入后剂量评估。然而,CT中的软组织对比度较差导致目标轮廓中的显着变化,导致感兴趣的器官的剂量计算不正确。基于CT-MR融合的方法已经提倡利用CT(种子鉴定)和MRI(软组织可见性)的互补能力,并证明提供了更准确的剂量测定计算。然而,CT中的种子分割需要手动审查,并且精度受重建的体素分辨率的限制。此外,CT沉积对患者的大量辐射。在本文中,我们提出了一种基于X射线和MRI的后植入后剂量测定方法。通过求解组合优化问题,使用三个X射线图像本地化种子,并且所识别的种子通过基于强度的点对数值登记到MR图像。我们使用几何和高斯滤波预处理MR图像。为了适应潜在的软组织变形,我们的注册分两步进行,初始仿射变换和局部可变形登记。一种进化优化器与点对数相似度指标用于仿射登记。然后通过具有外部和内部力约束的可变形登记步骤调整局部前列腺变形和种子迁移。我们在六个患者数据集中测试了我们的算法,在<30秒内实现了(1.2±0.8)mm的登记误差。我们所提出的方法有可能成为植入后剂量测定的快速且经济高效的解决方案,其具有等同的准确性作为基于CT-MR融合的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号